XPH ETF largest holding is DFTX:CA at 2.88% as of Jun 30, 2026
State Street SPDR S&P Pharmaceuticals ETF
DFTX:CA is XPH's largest holding at 2.88% of the fund as of Jun 30, 2026. XPH is State Street SPDR S&P Pharmaceuticals ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Share chg | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Definium Therapeutics, Inc. Common Shares | 2.88% | 2.9% | 290,045 | -51.9K | - | - |
| 2 | M | Mbx Biosciences IncHealth Care · Biotechnology | 2.81% | 5.7% | 217,506 | +904 | Health Care | Biotechnology |
| Share changes, sector and industry · Pro | ||||||||
| 3 | A | Alumis Inc | 2.05% | 7.7% | 336,026 | |||
| 4 | E | Enliven Therapeutics Inc | 2.04% | 9.8% | 182,178 | |||
| 5 | T | Trevi Therapeutics Inc. | 2.02% | 11.8% | 503,029 | |||
| 6 | A | Amylyx Pharmaceuticals Inc | 2.01% | 13.8% | 500,791 | |||
| 7 | M | Maze Therapeutics Inc | 1.98% | 15.8% | 274,078 | |||
| 8 | M | Veradermics Inc | 1.98% | 17.8% | 72,490 | |||
| 9 | — | Ataibeckley Inc. | 1.98% | 19.8% | 1,783,234 | |||
| 10 | L | Ligand Pharmaceuticals, Inc. | 1.95% | 21.7% | 27,150 | |||
| 11 | N | Nektar Therapeutics Class A | 1.94% | 23.6% | 118,714 | |||
| 12 | — | Harrow Health Inc | 1.89% | 25.5% | 187,760 | |||
| 13 | C | Crinetics Pharmaceuticals Inc | 1.85% | 27.4% | 196,404 | |||
| 14 | E | Edgewise Therapeutics Inc. | 1.84% | 29.2% | 204,753 | |||
| 15 | N | Nuvation Bio Inc | 1.84% | 31.1% | 1,471,749 | |||
| 16 | — | Liquidia Technologies Inc | 1.83% | 32.9% | 103,303 | |||
| 17 | C | Corcept Therapeutics Inc | 1.77% | 34.7% | 86,284 | |||
| 18 | E | Eyepoint Pharmaceuticals Inc.(eypt) | 1.77% | 36.4% | 546,682 | |||
| 19 | W | Wave Life Sciences Ltd | 1.68% | 38.1% | 1,190,929 | |||
| 20 | A | Amneal Pharmaceuticals Inc. | 1.67% | 39.8% | 439,990 | |||
| 21 | O | Ocular Therapeutix Inc | 1.67% | 41.5% | 771,241 | |||
| 22 | E | Elanco Animal Health, Inc Cvr | 1.66% | 43.1% | 294,733 | |||
| 23 | — | Pacira Pharm Inc | 1.65% | 44.8% | 287,812 | |||
| 24 | T | Tarsus Pharmaceuticals Inc | 1.65% | 46.4% | 110,021 | |||
| 25 | J | Johnson & Johnson - | 1.64% | 48.1% | 28,269 | |||
| 26 | C | Collegium Pharmaceutical Inc | 1.62% | 49.7% | 193,694 | |||
| 27 | V | Viatris Inc. | 1.61% | 51.3% | 427,432 | |||
| 28 | M | Merck & Company Inc | 1.60% | 52.9% | 56,604 | |||
| 29 | J | Jazz Pharmaceuticals Plc. | 1.60% | 54.5% | 29,357 | |||
| 30 | L | Eli Lilly & Co. | 1.59% | 56.1% | 5,937 | |||
| 31 | — | Indivior Pharmaceuticals, Inc. Ordinary Shares | 1.58% | 57.7% | 176,962 | |||
| 32 | S | Supernus Pharmaceuticals Inc | 1.58% | 59.2% | 149,499 | |||
| 33 | A | Ani Pharmaceuticals Inc | 1.57% | 60.8% | 82,359 | |||
| 34 | H | Harmony Biosciences, Llc | 1.57% | 62.4% | 189,981 | |||
| 35 | R | Royalty Pharma Plc Class A Ordinary Share | 1.57% | 63.9% | 123,635 | |||
| 36 | B | Bristol-Myers Squibb Co. | 1.54% | 65.5% | 121,234 | |||
| 37 | O | Omeros Corp | 1.53% | 67.0% | 660,846 | |||
| 38 | O | Organon & Co | 1.53% | 68.5% | 503,786 | |||
| 39 | E | Esperion Therapeutics Inc | 1.51% | 70.1% | 2,146,699 | |||
| 40 | B | Bioage Labs Inc | 1.50% | 71.6% | 270,285 | |||
| 41 | P | Prestige Consumer Healthcare Inc | 1.50% | 73.1% | 137,198 | |||
| 42 | P | Perrigo Company Plc Ordinary Shares | 1.50% | 74.6% | 603,461 | |||
| 43 | A | Axsome Therapeutics, Inc. | 1.48% | 76.0% | 27,365 | |||
| 44 | — | Xeris Pharmaceuticals Inc | 1.45% | 77.5% | 776,677 | |||
| 45 | I | Innoviva Inc | 1.43% | 78.9% | 293,075 | |||
| 46 | P | Pfizer Inc | 1.40% | 80.3% | 263,309 | |||
| 47 | Z | Zoetis Inc, Class A | 1.40% | 81.7% | 82,924 | |||
| 48 | P | Phibro Animal Health Corp | 1.38% | 83.1% | 180,645 | |||
| 49 | E | Eton Pharmaceuticals Inc. | 1.35% | 84.4% | 159,226 | |||
| 50 | R | Rapport Therapeutics, Inc. | 1.32% | 85.8% | 152,442 | |||
| More holdings · Pro | ||||||||
XPH ETF All Holdings
XPH holdings total 67 positions. The top 10 holdings account for 21.7% of the fund, led by Definium Therapeutics, Inc. Common Shares at 2.9%, Mbx Biosciences Inc at 2.8%, Alumis Inc Common Stock USD 0.0001 at 2.0%.
XPH portfolio concentration is well-diversified, with the top 10 representing 21.7% of total assets. The largest sector exposure is Health Care at 84.1%.
XPH sectors provide a detailed breakdown. XPH overlap shows how holdings compare to other funds in your portfolio.
XPH ETF Holdings
67 of 67 holdings
- 1
Definium Therapeutics, Inc. Common Shares
DFTX:CAUnknown2.88% - 2
Mbx Biosciences Inc
MBXHealth Care2.81% - 3
Alumis Inc Common Stock USD 0.0001
ALMSIndustrials2.05% - 4
Enliven Therapeutics Inc
ELVNHealth Care2.04% - 5
Trevi Therapeutics Inc.
TRVIHealth Care2.02% - 6
Amylyx Pharmaceuticals Inc
AMLXHealth Care2.01% - 7
Maze Therapeutics Inc
MAZEHealth Care1.98% - 8
Veradermics Inc
MANEUnknown1.98% - 9
Ataibeckley Inc.
ATAIHealth Care1.98% - 10
Ligand Pharmaceuticals, Inc.
LGNDHealth Care1.95% - 11
Nektar Therapeutics Class A
NKTRUnknown1.94% - 12
Harrow Health Inc Com
HROWHealth Care1.89% - 13
Crinetics Pharmaceuticals Inc Com
CRNXHealth Care1.85% - 14
Edgewise Therapeutics Inc.
EWTXHealth Care1.84% - 15
Nuvation Bio Inc
NUVBHealth Care1.84% - 16
Liquidia Technologies Inc
LQDAHealth Care1.83% - 17
Corcept Therapeutics Incorporated
CORTHealth Care1.77% - 18
Eyepoint Pharmaceuticals Inc.(eypt)
EYPTHealth Care1.77% - 19
Wave Life Sciences Ltd
WVEHealth Care1.68% - 20
Amneal Pharmaceuticals Inc.
AMRXHealth Care1.67% - 21
Ocular Therapeutix Inc
OCULHealth Care1.67% - 22
Elanco Animal Health, Inc Cvr
ELANHealth Care1.66% - 23
Pacira Pharm Inc
PCRXHealth Care1.65% - 24
Tarsus Pharmaceuticals Inc
TARSHealth Care1.65% - 25
Johnson & Johnson - Common
JNJHealth Care1.64% - 26
Collegium Pharmaceutical Inc
COLLHealth Care1.62% - 27
Viatris Inc.
VTRSHealth Care1.61% - 28
Merck & Company Inc
MRKHealth Care1.60% - 29
Jazz Pharmaceuticals Plc.
JAZZHealth Care1.60% - 30
Eli Lilly & Co.
LLYHealth Care1.59% - 31
Indivior Pharmaceuticals, Inc. Ordinary Shares
INDV:MBUnknown1.58% - 32
Supernus Pharmaceuticals Inc
SUPNHealth Care1.58% - 33
Ani Pharmaceuticals Inc
ANIPHealth Care1.57% - 34
Harmony Biosciences, Llc
HRMYHealth Care1.57% - 35
Royalty Pharma Plc Class A Ordinary Share
RPD:DUFinancials1.57% - 36
Bristol-Myers Squibb Co.
BMYHealth Care1.54% - 37
Omeros Corp Com
OMERHealth Care1.53% - 38
Organon & Co
OGNHealth Care1.53% - 39
Esperion Therapeutics Inc
ESPRHealth Care1.51% - 40
Bioage Labs Inc Common Stock Usd.00001
BIOAHealth Care1.50% - 41
Prestige Consumer Healthcare Inc
PBHConsumer Staples1.50% - 42
Perrigo Company Plc Ordinary Shares
PRGOConsumer Staples1.50% - 43
Axsome Therapeutics, Inc.
AXSMHealth Care1.48% - 44
Xeris Pharmaceuticals Inc Com
XERSHealth Care1.45% - 45
Innoviva Inc
INVAHealth Care1.43% - 46
Pfizer Inc
PFEHealth Care1.40% - 47
Zoetis Inc, Class A
ZTSHealth Care1.40% - 48
Phibro Animal Health Corp
PAHCHealth Care1.38% - 49
Eton Pharmaceuticals Inc.
ETONHealth Care1.35% - 50
Rapport Therapeutics, Inc.
RAPPHealth Care1.32% - 51
Arvinas Inc
ARVNHealth Care1.25% - 52
Amphastar Pharmaceuticals Inc
AMPHHealth Care1.20% - 53
Zevra Therapeutics Inc
ZVRAHealth Care1.19% - 54
Alto Neuroscience, Inc., Series C
ANROHealth Care1.15% - 55
Cormedix Inc Com
CRMDHealth Care1.11% - 56
Phathom Pharmaceuticals Inc Phat
PHATHealth Care1.10% - 57
Septerna Inc
SEPNHealth Care0.98% - 58
Relmada Therapeutics Inc Common Stock
RLMDHealth Care0.96% - 59
Theravance Biopharma Inc
TBPHHealth Care0.95% - 60
Aclaris Therapeutics Inc
ACRSHealth Care0.92% - 61
Lb Pharmaceuticals Inc.
LBRXUnknown0.81% - 62
Ara Us Hospitality Trust
AQSTHealth Care0.77% - 63
Fulcrum Therapeutics Inc Com
FULCHealth Care0.69% - 64
Lexicon Pharmaceut Com New
LXRXHealth Care0.60% - 65
Evolus Inc
EOLSHealth Care0.52% - 66
Ssi Us Gov Money Market Class
NMFUnknown0.06% - 67
US Dollar
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Definium Therapeutics, Inc. Common Shares | DFTX:CA | 2.880% | ||
| 2 | Mbx Biosciences Inc | MBX | 2.810% | ||
| 3 | Alumis Inc Common Stock USD 0.0001 | ALMS | 2.050% | ||
| 4 | Enliven Therapeutics Inc | ELVN | 2.040% | ||
| 5 | Trevi Therapeutics Inc. | TRVI | 2.020% | ||
| 6 | Amylyx Pharmaceuticals Inc | AMLX | 2.010% | ||
| 7 | Maze Therapeutics Inc | MAZE | 1.980% | ||
| 8 | Veradermics Inc | MANE | 1.980% | ||
| 9 | Ataibeckley Inc. | ATAI | 1.980% | ||
| 10 | Ligand Pharmaceuticals, Inc. | LGND | 1.950% | ||
| 11 | Nektar Therapeutics Class A | NKTR | 1.940% | ||
| 12 | Harrow Health Inc Com | HROW | 1.890% | ||
| 13 | Crinetics Pharmaceuticals Inc Com | CRNX | 1.850% | ||
| 14 | Edgewise Therapeutics Inc. | EWTX | 1.840% | ||
| 15 | Nuvation Bio Inc | NUVB | 1.840% | ||
| 16 | Liquidia Technologies Inc | LQDA | 1.830% | ||
| 17 | Corcept Therapeutics Incorporated | CORT | 1.770% | ||
| 18 | Eyepoint Pharmaceuticals Inc.(eypt) | EYPT | 1.770% | ||
| 19 | Wave Life Sciences Ltd | WVE | 1.680% | ||
| 20 | Amneal Pharmaceuticals Inc. | AMRX | 1.670% | ||
| 21 | Ocular Therapeutix Inc | OCUL | 1.670% | ||
| 22 | Elanco Animal Health, Inc Cvr | ELAN | 1.660% | ||
| 23 | Pacira Pharm Inc | PCRX | 1.650% | ||
| 24 | Tarsus Pharmaceuticals Inc | TARS | 1.650% | ||
| 25 | Johnson & Johnson - Common | JNJ | 1.640% | ||
| 26 | Collegium Pharmaceutical Inc | COLL | 1.620% | ||
| 27 | Viatris Inc. | VTRS | 1.610% | ||
| 28 | Merck & Company Inc | MRK | 1.600% | ||
| 29 | Jazz Pharmaceuticals Plc. | JAZZ | 1.600% | ||
| 30 | Eli Lilly & Co. | LLY | 1.590% | ||
| 31 | Indivior Pharmaceuticals, Inc. Ordinary Shares | INDV:MB | 1.580% | ||
| 32 | Supernus Pharmaceuticals Inc | SUPN | 1.580% | ||
| 33 | Ani Pharmaceuticals Inc | ANIP | 1.570% | ||
| 34 | Harmony Biosciences, Llc | HRMY | 1.570% | ||
| 35 | Royalty Pharma Plc Class A Ordinary Share | RPD:DU | 1.570% | ||
| 36 | Bristol-Myers Squibb Co. | BMY | 1.540% | ||
| 37 | Omeros Corp Com | OMER | 1.530% | ||
| 38 | Organon & Co | OGN | 1.530% | ||
| 39 | Esperion Therapeutics Inc | ESPR | 1.510% | ||
| 40 | Bioage Labs Inc Common Stock Usd.00001 | BIOA | 1.500% | ||
| 41 | Prestige Consumer Healthcare Inc | PBH | 1.500% | ||
| 42 | Perrigo Company Plc Ordinary Shares | PRGO | 1.500% | ||
| 43 | Axsome Therapeutics, Inc. | AXSM | 1.480% | ||
| 44 | Xeris Pharmaceuticals Inc Com | XERS | 1.450% | ||
| 45 | Innoviva Inc | INVA | 1.430% | ||
| 46 | Pfizer Inc | PFE | 1.400% | ||
| 47 | Zoetis Inc, Class A | ZTS | 1.400% | ||
| 48 | Phibro Animal Health Corp | PAHC | 1.380% | ||
| 49 | Eton Pharmaceuticals Inc. | ETON | 1.350% | ||
| 50 | Rapport Therapeutics, Inc. | RAPP | 1.320% | ||
| 51 | Arvinas Inc | ARVN | 1.250% | ||
| 52 | Amphastar Pharmaceuticals Inc | AMPH | 1.200% | ||
| 53 | Zevra Therapeutics Inc | ZVRA | 1.190% | ||
| 54 | Alto Neuroscience, Inc., Series C | ANRO | 1.150% | ||
| 55 | Cormedix Inc Com | CRMD | 1.110% | ||
| 56 | Phathom Pharmaceuticals Inc Phat | PHAT | 1.100% | ||
| 57 | Septerna Inc | SEPN | 0.980% | ||
| 58 | Relmada Therapeutics Inc Common Stock | RLMD | 0.960% | ||
| 59 | Theravance Biopharma Inc | TBPH | 0.950% | ||
| 60 | Aclaris Therapeutics Inc | ACRS | 0.920% | ||
| 61 | Lb Pharmaceuticals Inc. | LBRX | 0.810% | ||
| 62 | Ara Us Hospitality Trust | AQST | 0.770% | ||
| 63 | Fulcrum Therapeutics Inc Com | FULC | 0.690% | ||
| 64 | Lexicon Pharmaceut Com New | LXRX | 0.600% | ||
| 65 | Evolus Inc | EOLS | 0.520% | ||
| 66 | Ssi Us Gov Money Market Class | NMF | 0.060% | ||
| 67 | US Dollar | - | 0.000% |










































